Conferences

November 15, 2024

New study shows IVIG replacement lowers infection risk in CLL and NHL patients, highlighting the need for better IgG testing and IgRT guidelines.

October 22, 2024

Is it safe for relapsed/refractory non-Hodgkin lymphoma patients, including DLBCL, to receive CAR T-cell therapy in an outpatient setting?

October 15, 2024

Dr. Mark Roschewski shared with HealthTree about his presentation at ASH 2023 on the results of a regimen known as ViPOR, designed for patients with R/R DLBCL.

October 09, 2024

Explore new CAR T and bispecific antibody strategies in myeloma care from the IMS 2024 conference, advancing treatment outcomes and patient care.

October 07, 2024

Learn about new IMS 2024 findings on high-risk multiple myeloma, evolving definitions, improved genetic testing, and cutting-edge treatment strategies.

October 04, 2024

Get the latest updates on myeloma research and treatment from the 2024 International Myeloma Society. HealthTree brings you expert interviews and key takeaways.

September 08, 2024

Discover how to manage talquetamab’s side effects with myeloma specialist Dr. Chari.

August 27, 2024

Dr. Deaglio outlines two CLL groups that need special attention from researchers to advance treatment options.

August 19, 2024

Dr. Claudio Cerchione shares multiple myeloma updates from ASCO & EHA 2024, covering novel treatments and diagnostic innovations.

August 08, 2024

Discover the results from CARTITUDE-4 subgroup analysis with Dr. Luciano Costa, for high-risk multiple myeloma patients at ASCO 2024.